These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11172812)

  • 21. TGFbeta receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes.
    Osterlund C; Fried G
    Mol Hum Reprod; 2000 Jun; 6(6):498-503. PubMed ID: 10825365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.
    Taniguchi A; Matsuzaki K; Nakano K; Kan M; McKeehan WL
    In Vitro Cell Dev Biol Anim; 1998 Mar; 34(3):232-8. PubMed ID: 9557941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA; Doré JJ; Arline SL; Garamszegi N; Leof EB
    J Biol Chem; 1998 Sep; 273(36):23118-25. PubMed ID: 9722540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for specificity of TGFβ family receptor small molecule inhibitors.
    Ogunjimi AA; Zeqiraj E; Ceccarelli DF; Sicheri F; Wrana JL; David L
    Cell Signal; 2012 Feb; 24(2):476-483. PubMed ID: 21983015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
    Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
    Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of specificity in TGF-beta signal transduction.
    Chen YG; Hata A; Lo RS; Wotton D; Shi Y; Pavletich N; Massagué J
    Genes Dev; 1998 Jul; 12(14):2144-52. PubMed ID: 9679059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
    Bennett D; Alphey L
    Nat Genet; 2002 Aug; 31(4):419-23. PubMed ID: 12134149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.
    Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J
    Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.
    Gilboa L; Wells RG; Lodish HF; Henis YI
    J Cell Biol; 1998 Feb; 140(4):767-77. PubMed ID: 9472030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Drosophila type II receptor, Wishful thinking, binds BMP and myoglianin to activate multiple TGFbeta family signaling pathways.
    Lee-Hoeflich ST; Zhao X; Mehra A; Attisano L
    FEBS Lett; 2005 Aug; 579(21):4615-21. PubMed ID: 16098524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A divergent member of the transforming growth factor beta receptor family from Schistosoma mansoni is expressed on the parasite surface membrane.
    Davies SJ; Shoemaker CB; Pearce EJ
    J Biol Chem; 1998 May; 273(18):11234-40. PubMed ID: 9556614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
    Liu F; Pouponnot C; Massagué J
    Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of a PDZ protein that interacts with activin type II receptors.
    Shoji H; Tsuchida K; Kishi H; Yamakawa N; Matsuzaki T; Liu Z; Nakamura T; Sugino H
    J Biol Chem; 2000 Feb; 275(8):5485-92. PubMed ID: 10681527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad2 phosphorylation by type I receptor: contribution of arginine 462 and cysteine 463 In the C terminus of Smad2 for specificity.
    Yakymovych I; Heldin CH; Souchelnytskyi S
    J Biol Chem; 2004 Aug; 279(34):35781-7. PubMed ID: 15210694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.
    Osman A; Niles EG; Verjovski-Almeida S; LoVerde PT
    PLoS Pathog; 2006 Jun; 2(6):e54. PubMed ID: 16789838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
    McLean S; Bhattacharya M; Di Guglielmo GM
    Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
    Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
    J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.